Non-invasive diagnostic biomarkers for estimating the onset time of permanent cerebral ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 11, 2014, Pages 1848-1855

  Berthet, Carole ^a   Xin, Lijing ^a,b   Buscemi, Lara ^a   Benakis, Corinne ^a   Gruetter, Rolf ^b,c,d   Hirt, Lorenz ^a   Lei, Hongxia ^a,b,d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

biomarkers; magnetic resonance spectroscopy; MCAO; mouse; stroke; stroke onset biomarkers

Indexed keywords

4 AMINOBUTYRIC ACID; BIOLOGICAL MARKER; GLUTAMINE; N ACETYLASPARTIC ACID; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; ANIMAL; DISEASE MODEL; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; PATHOLOGY; TIME;

ANIMALS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED ICR; TIME FACTORS;

EID: 84922265980     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.155     Document Type: Article

References (39)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New Engl J Med 1995; 333: 1581-1588.
2. Furlan AJ. Acute ischemic stroke: new strategies for management and prevention. Interview by Wayne Kuznar. Geriatrics 1999; 54: 47-52.
3. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73.
4. Hossmann KA. Pathophysiological basis of translational stroke research. Folia Neuropathol 2009; 47: 213-227.
5. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009; 40: 2244-2250.
6. Malisza KL, Kozlowski P, Peeling J. A review of in vivo 1H magnetic resonance spectroscopy of cerebral ischemia in rats. Biochem Cell Biol 1998; 76: 487-496.
7. Berthet C, Lei H, Gruetter R, Hirt L. Early predictive biomarkers for lesion after transient cerebral ischemia. Stroke 2011; 42: 799-805.
8. Hossmann K-A. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab 2012; 32: 1310-1316.
9. Barber PA, Hoyte L, Kirk D, Foniok T, Buchan A, Tuor U. Early T1-and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T. Neurosci Lett 2005; 388: 54-59.
10. Bentue-Ferrer D, Reymann JM, Bagot H, Driessche J, Certaines J, Allain H. Aminergic neurotransmitter and water content changes in rats after transient forebrain ischemia. J Neurochem 1986; 47: 1672-1677.
11. Lei H, Berthet C, Hirt L, Gruetter R. Evolution of the neurochemical profile after transient focal cerebral ischemia in the mouse brain. J Cereb Blood Flow Metab 2009; 29: 811-819.
12. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007; 87: 179-197.
13. Gyngell ML, Busch E, Schmitz B, Kohno K, Back T, Hoehn-Berlage M et al. Evolution of acute focal cerebral ischaemia in rats observed by localized 1H MRS, diffusionweighted MRI, and electrophysiological monitoring. NMR Biomed 1995; 8: 206-214.
14. Hirt L, Badaut J, Thevenet J, Granziera C, Regli L, Maurer F et al. D-JNKI1, a cellpenetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke 2004; 35: 1738-1743.
15. Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, Bachmann A et al. Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 2004; 35: 566-571.
16. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
17. Hossmann KA, Traystman RJ. Cerebral blood flow and the ischemic penumbra. Handb Clin Neurol 2009; 92: 67-92.
18. Alderman JL, Shellenberger MK. Gamma-aminobutyric acid (GABA) in the rat brain: re-evaluation of sampling procedures and the post-mortem increase. J Neurochem 1974; 22: 937-940.
19. Bown AW, Shelp BJ. The metabolism and functions of [gamma]-aminobutyric acid. Plant Physiol 1997; 115: 1-5.
20. Erdo SL. Postmortem increase of GABA levels in peripheral rat tissues: prevention by 3-mercapto-propionic acid. J Neural Transm 1984; 60: 303-314.
21. Wood JD, Watson WJ, Ducker AJ. The effect of hypoxia on brain gammaaminobutyric acid levels. J Neurochem 1968; 15: 603-608.
22. Perry TL, Hansen S, Gandham SS. Postmortem changes of amino compounds in human and rat brain. J Neurochem 1981; 36: 406-410.
23. Petroff OA, Ogino T, Alger JR. High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes. J Neurochem 1988; 51: 163-171.
24. Norberg K, Siesjo BK. Cerebral metabolism in hypoxic hypoxia. I. Pattern of activation of glycolysis: a re-evaluation. Brain Res. 1975; 86: 31-44.
25. Nonaka M, Yoshimine T, Kohmura E, Wakayama A, Yamashita T, Hayakawa T. Changes in brain organic osmolytes in experimental cerebral ischemia. J Neurol Sci 1998; 157: 25-30.
26. Lowry OH, Passonneau JV, Hasselberger FX, Schulz DW. Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J Biol Chem 1964; 239: 18-30.
27. Behar KL, den Hollander JA, Petroff OA, Hetherington HP, Prichard JW, Shulman RG. Effect of hypoglycemic encephalopathy upon amino acids, high-energy phosphates, and pHi in the rat brain in vivo: detection by sequential 1H and 31P NMR spectroscopy. J Neurochem 1985; 44: 1045-1055.
28. Sutherland GR, Tyson RL, Auer RN. Truncation of the krebs cycle during hypoglycemic coma. Med Chem 2008; 4: 379-385.
29. Sager TN, Hansen AJ, Laursen H. Correlation between N-acetylaspartate levels and histopathologic changes in cortical infarcts of mice after middle cerebral artery occlusion. J Cereb Blood Flow Metab 2000; 20: 780-788.
30. Sager TN, Laursen H, Hansen AJ. Changes in N-acetyl-aspartate content during focal and global brain ischemia of the rat. J Cereb Blood Flow Metab 1995; 15: 639-646.
31. Matsumoto K, Lo EH, Pierce AR, Halpern EF, Newcomb R. Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia. J Cereb Blood Flow Metab 1996; 16: 114-124.
32. Pan J, Konstas AA, Bateman B, Ortolano GA, Pile-Spellman J. Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology 2007; 49: 93-102.
33. Schuier FJ, Hossmann KA. Experimental brain infarcts in cats. II. Ischemic brain edema. Stroke 1980; 11: 593-601.
34. Schielke GP, Moises HC, Betz AL. Blood to brain sodium transport and interstitial fluid potassium concentration during early focal ischemia in the rat. J Cereb Blood Flow Metab 1991; 11: 466-471.
35. Wang Y, Hu W, Perez-Trepichio AD, Ng TC, Furlan AJ, Majors AW et al. Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia. Stroke 2000; 31: 1386-1391, discussion 92.
36. Jones SC, Kharlamov A, Yanovski B, Kim DK, Easley KA, Yushmanov VE et al. Stroke onset time using sodium MRI in rat focal cerebral ischemia. Stroke 2006; 37: 883-888.
37. Nonaka M, Yoshimine T, Kumura E, Kohmura E, Wakayama A, Hayakawa T. Decrease in N-acetylaspartate without commensurate accumulation of acetate in focal cerebral ischemia in rat. Neurol Res 1999; 21: 771-774.
38. Mekle R, Mlynarik V, Gambarota G, Hergt M, Krueger G, Gruetter R. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med 2009; 61: 1279-1285.
39. Oz G, Alger JR, Barker PB, Bartha R, Bizzi A, Boesch C et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014; 270: 658-679.